A rare case of lymphangiomyomatosis treated with leuprolide acetate: five-years follow-up.
E Bastu, S E Akhan, B Karamustafaoglu, F Gungor-Ugurlucan, H Sozen, A C Iyibozkurt
Index: Eur. J. Gynaecol. Oncol. 34(3) , 278-9, (2013)
Full Text: HTML
Abstract
Lymphangiomyomatosis (LAM) is a rare and systemic disease that is characterized by the abnormal proliferation of smooth muscle-like cells in the lungs and along the axial lymphatic system. The authors herein present a rare case of LAM that was treated with long-term use of leuprolide acetate, a gonadotropin-releasing hormone analogue (GnRHa).
Related Compounds
Related Articles:
2014-05-01
[Am. J. Physiol. Regul. Integr. Comp. Physiol. 306(9) , R627-35, (2014)]
2013-03-01
[Med. Oncol. 30(1) , 354, (2013)]
Novasure as a mechanical endometrial preparation agent in large uteri.
2012-01-01
[JSLS 16(4) , 537-41, (2012)]
Comprehensive management of diffuse leiomyomatosis in a patient with Alport syndrome.
2013-12-01
[P. R. Health Sci. J. 32(4) , 200-2, (2013)]
2013-05-01
[Bull. Cancer 100(5) , 415-6, (2013)]